TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
DERM

Journey Medical Corp

Healthcare · Drug Manufacturers - Specialty & Generic

6.30$ -2.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement DERM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +0.0% +209.4% -79.9% +832.4% -17.5% +27.5% +41.8% +16.7% +7.5% -29.1% +10.2%
– – – – – +795.6% +38.6% +119.8% -4.1% -13.4% -21.7% +20.6%
– +0.0% +209.4% -79.9% +806.5% -40.8% +22.7% +3.7% +38.1% +22.4% -32.9% +4.0%
– +117.6% +24.4% +25.5% -22.9% – – – -33.9% -31.1% +30.7% -95.1%
– +113.8% +69.5% +139.3% +140.0% -88.9% +15.5% +80.4% +49.3% -19.2% -16.3% +10.4%
– +123.3% +30.0% +169.3% -16.3% -92.5% +15.5% +198.5% +6.8% -22.5% -10.4% -8.3%
– – – – – – +49.3% -544.3% – – – –
– -3.9% +947.6% +428.6% +92.1% -98.4% +173.7% +907.7% -71.3% -15.9% +59.0% +37.0%
– – – – – – +42.9% -692.2% – – – –
– -2,106.5% – +69.0% -103.7% – +35.6% -12.6% -96.1% +250.8% -72.4% -1.6%
– – – – – – +45.7% -932.7% – – – –
– – – – – – +44.1% -453.2% – – -537.1% –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?